Yassa Murat, Yirmibes Cihangir, Cavusoglu Gul, Eksi Hazal, Dogu Cevdet, Usta Canberk, Mutlu Memis, Birol Pinar, Gulumser Cagri, Tug Niyazi
Department of Obstetrics and Gynecology, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital, Istanbul, Turkey.
Obstetrics and Gynecology, Private Clinic, Ankara, Turkey.
J Matern Fetal Neonatal Med. 2020 Nov;33(22):3820-3826. doi: 10.1080/14767058.2020.1798398. Epub 2020 Jul 28.
The emerging evidence for the asymptomatic carriers of SARS-CoV-2 infection emphasized the critical need for universal screening of pregnant women.
This study aimed to present the prevalence of overall and asymptomatic SARS-CoV-2 infection rates in pregnant women admitted to the hospital, and assess the diagnostic accuracy of maternal symptoms and lung ultrasound (LUS) findings in detecting the infection.
This prospective cohort study was conducted at a single tertiary center in Istanbul, Turkey, for a month period starting from 27 April 2020. Women with a confirmed pregnancy regardless of the gestational week admitted to the obstetric unit with any indication were consecutively underwent LUS and PCR testing for SARS-CoV-2.
A total of 296 patients were included for the final analysis. The universal screening strategy diagnosed 23 pregnant women (7.77%) with SARS-CoV-2 infection. The rate of symptomatic and asymptomatic patients diagnosed with SARS-CoV-2 was found as 3.72% ( = 11) and 4.05% ( = 12), respectively. Four of nine women who underwent a second testing for SARS-CoV-2 upon abnormal LUS findings were found positive eventually (17.4%, = 4/23). The asymptomatic pregnant women with LUS score of 1 and those with normal LUS findings were considered as likely to be normal. Symptomatic patients with LUS score of 1 and those with score of 2 or 3 were considered as abnormal. On a secondary diagnostic performance analysis, the positive predictive value and the sensitivity were found as 44% and 47.8% for the triage based on maternal symptoms and, 82.3% and 60.9% for the triage based on LUS, respectively.
A one-month trial period of universal testing for SARS-CoV-2 infection with RT-PCR in pregnant women who admitted to the hospital showed an overall and asymptomatic infection diagnose rate of 7.77% and 4%, respectively. Using lung ultrasound was found more predictive in detecting the infection than the use of symptomatology solely.
新型冠状病毒2(SARS-CoV-2)感染无症状携带者的新证据强调了对孕妇进行普遍筛查的迫切需求。
本研究旨在呈现入院孕妇中SARS-CoV-2总体感染率和无症状感染率,并评估孕妇症状和肺部超声(LUS)检查结果在检测感染方面的诊断准确性。
本前瞻性队列研究于2020年4月27日起在土耳其伊斯坦布尔的一家单一三级中心进行,为期一个月。确诊妊娠的女性,无论孕周大小,因任何指征入住产科病房,均连续接受SARS-CoV-2的LUS和PCR检测。
共296例患者纳入最终分析。普遍筛查策略诊断出23例(7.77%)孕妇感染SARS-CoV-2。确诊感染SARS-CoV-2的有症状和无症状患者比例分别为3.72%(n = 11)和4.05%(n = 12)。9例LUS检查结果异常后接受第二次SARS-CoV-2检测的女性中,最终4例呈阳性(17.4%,n = 4/23)。LUS评分为1分的无症状孕妇以及LUS检查结果正常的孕妇被认为可能正常。LUS评分为1分的有症状患者以及评分为2分或3分的患者被认为异常。在二次诊断性能分析中,基于孕妇症状进行分诊的阳性预测值和敏感性分别为44%和47.8%,基于LUS进行分诊的阳性预测值和敏感性分别为82.3%和60.9%。
对入院孕妇进行为期一个月的SARS-CoV-2感染实时荧光定量聚合酶链反应(RT-PCR)普遍检测的试验期显示,总体感染率和无症状感染率分别为7.77%和4%。结果发现,使用肺部超声在检测感染方面比单纯使用症状学更具预测性。